Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Hepatotoxicity with antibody maytansinoid conjugates: A review of preclinical and clinical findings.

Taplin S, Vashisht K, Walles M, Calise D, Kluwe W, Bouchard P, Johnson R.

J Appl Toxicol. 2018 May;38(5):600-615. doi: 10.1002/jat.3582. Epub 2018 Feb 1. Review.

PMID:
29388692
2.

Therapeutic Benefit and Gene Network Regulation by Combined Gene Transfer of Apelin, FGF2, and SERCA2a into Ischemic Heart.

Renaud-Gabardos E, Tatin F, Hantelys F, Lebas B, Calise D, Kunduzova O, Masri B, Pujol F, Sicard P, Valet P, Roncalli J, Chaufour X, Garmy-Susini B, Parini A, Prats AC.

Mol Ther. 2018 Mar 7;26(3):902-916. doi: 10.1016/j.ymthe.2017.11.007. Epub 2017 Nov 16.

3.

Local production of tenascin-C acts as a trigger for monocyte/macrophage recruitment that provokes cardiac dysfunction.

Abbadi D, Laroumanie F, Bizou M, Pozzo J, Daviaud D, Delage C, Calise D, Gaits-Iacovoni F, Dutaur M, Tortosa F, Renaud-Gabardos E, Douin-Echinard V, Prats AC, Roncalli J, Parini A, Pizzinat N.

Cardiovasc Res. 2018 Jan 1;114(1):123-137. doi: 10.1093/cvr/cvx221.

PMID:
29136112
4.

Apelin modulates pathological remodeling of lymphatic endothelium after myocardial infarction.

Tatin F, Renaud-Gabardos E, Godet AC, Hantelys F, Pujol F, Morfoisse F, Calise D, Viars F, Valet P, Masri B, Prats AC, Garmy-Susini B.

JCI Insight. 2017 Jun 15;2(12). pii: 93887. doi: 10.1172/jci.insight.93887. eCollection 2017 Jun 15.

5.

Lens Capsule Perforation Without Inflammation in 4 Rabbits From Intravitreal Injection Studies.

Farman C, Schuetz C, Lorget F, Bantseev V, Calise D, Thackaberry EA.

Vet Pathol. 2017 Sep;54(5):870-876. doi: 10.1177/0300985817705169. Epub 2017 May 11.

PMID:
28494699
6.

Systems biology combining human- and animal-data miRNA and mRNA data identifies new targets in ureteropelvic junction obstruction.

Papadopoulos T, Casemayou A, Neau E, Breuil B, Caubet C, Calise D, Thornhill BA, Bachvarova M, Belliere J, Chevalier RL, Moulos P, Bachvarov D, Buffin-Meyer B, Decramer S, Auriol FC, Bascands JL, Schanstra JP, Klein J.

BMC Syst Biol. 2017 Mar 1;11(1):31. doi: 10.1186/s12918-017-0411-7.

7.

Apelin-13 administration protects against ischaemia/reperfusion-mediated apoptosis through the FoxO1 pathway in high-fat diet-induced obesity.

Boal F, Timotin A, Roumegoux J, Alfarano C, Calise D, Anesia R, Parini A, Valet P, Tronchere H, Kunduzova O.

Br J Pharmacol. 2016 Jun;173(11):1850-63. doi: 10.1111/bph.13485. Epub 2016 Apr 20.

8.

Apelin regulates FoxO3 translocation to mediate cardioprotective responses to myocardial injury and obesity.

Boal F, Roumegoux J, Alfarano C, Timotin A, Calise D, Anesia R, Drougard A, Knauf C, Lagente C, Roncalli J, Desmoulin F, Tronchere H, Valet P, Parini A, Kunduzova O.

Sci Rep. 2015 Nov 6;5:16104. doi: 10.1038/srep16104.

9.

Role of Sphingosine-1-Phosphate in Transplant Vasculopathy Evoked by Anti-HLA Antibody.

Trayssac M, Galvani S, Augé N, Sabbadini R, Calise D, Mucher E, Sallusto F, Thomsen M, Salvayre R, Nègre-Salvayre A.

Am J Transplant. 2015 Aug;15(8):2050-61. doi: 10.1111/ajt.13264. Epub 2015 Apr 30.

10.

Kinin B1 receptor antagonism is equally efficient as angiotensin receptor 1 antagonism in reducing renal fibrosis in experimental obstructive nephropathy, but is not additive.

Huart A, Klein J, Gonzalez J, Buffin-Meyer B, Neau E, Delage C, Calise D, Ribes D, Schanstra JP, Bascands JL.

Front Pharmacol. 2015 Feb 2;6:8. doi: 10.3389/fphar.2015.00008. eCollection 2015.

11.

Targeting PI3Kγ activity decreases vascular trauma-induced intimal hyperplasia through modulation of the Th1 response.

Smirnova NF, Gayral S, Pedros C, Loirand G, Vaillant N, Malet N, Kassem S, Calise D, Goudounèche D, Wymann MP, Hirsch E, Gadeau AP, Martinez LO, Saoudi A, Laffargue M.

J Exp Med. 2014 Aug 25;211(9):1779-92. doi: 10.1084/jem.20131276. Epub 2014 Jul 29.

12.

Transition from metabolic adaptation to maladaptation of the heart in obesity: role of apelin.

Alfarano C, Foussal C, Lairez O, Calise D, Attané C, Anesia R, Daviaud D, Wanecq E, Parini A, Valet P, Kunduzova O.

Int J Obes (Lond). 2015 Feb;39(2):312-20. doi: 10.1038/ijo.2014.122. Epub 2014 Jul 16.

13.

CD4+ T cells promote the transition from hypertrophy to heart failure during chronic pressure overload.

Laroumanie F, Douin-Echinard V, Pozzo J, Lairez O, Tortosa F, Vinel C, Delage C, Calise D, Dutaur M, Parini A, Pizzinat N.

Circulation. 2014 May 27;129(21):2111-24. doi: 10.1161/CIRCULATIONAHA.113.007101. Epub 2014 Mar 21.

PMID:
24657994
14.

Cardiac fibroblasts regulate sympathetic nerve sprouting and neurocardiac synapse stability.

Mias C, Coatrieux C, Denis C, Genet G, Seguelas MH, Laplace N, Rouzaud-Laborde C, Calise D, Parini A, Cussac D, Pathak A, Sénard JM, Galés C.

PLoS One. 2013 Nov 14;8(11):e79068. doi: 10.1371/journal.pone.0079068. eCollection 2013.

15.

Evaluation of polyelectrolyte complex-based scaffolds for mesenchymal stem cell therapy in cardiac ischemia treatment.

Ceccaldi C, Bushkalova R, Alfarano C, Lairez O, Calise D, Bourin P, Frugier C, Rouzaud-Laborde C, Cussac D, Parini A, Sallerin B, Fullana SG.

Acta Biomater. 2014 Feb;10(2):901-11. doi: 10.1016/j.actbio.2013.10.027. Epub 2013 Nov 5.

PMID:
24211733
16.

Dual effect of chemokine CCL7/MCP-3 in the development of renal tubulointerstitial fibrosis.

Gonzalez J, Mouttalib S, Delage C, Calise D, Maoret JJ, Pradère JP, Klein J, Buffin-Meyer B, Van der Veen B, Charo IF, Heeringa P, Duchene J, Bascands JL, Schanstra JP.

Biochem Biophys Res Commun. 2013 Aug 23;438(2):257-63. doi: 10.1016/j.bbrc.2013.07.025. Epub 2013 Jul 19.

17.

Anesthetic regimen for cardiac function evaluation by echocardiography in mice: comparison between ketamine, etomidate and isoflurane versus conscious state.

Lairez O, Lonjaret L, Ruiz S, Marchal P, Franchitto N, Calise D, Fourcade O, Mialet-Perez J, Parini A, Minville V.

Lab Anim. 2013 Oct;47(4):284-90. doi: 10.1177/0023677213496236. Epub 2013 Jul 17.

PMID:
23864007
18.

Role of serotonin 5-HT2A receptors in the development of cardiac hypertrophy in response to aortic constriction in mice.

Lairez O, Cognet T, Schaak S, Calise D, Guilbeau-Frugier C, Parini A, Mialet-Perez J.

J Neural Transm (Vienna). 2013 Jun;120(6):927-35. doi: 10.1007/s00702-013-1011-3. Epub 2013 Mar 30.

PMID:
23543114
19.

Role of endothelial AADC in cardiac synthesis of serotonin and nitrates accumulation.

Rouzaud-Laborde C, Hanoun N, Baysal I, Rech JS, Mias C, Calise D, Sicard P, Frugier C, Seguelas MH, Parini A, Pizzinat N.

PLoS One. 2012;7(7):e34893. doi: 10.1371/journal.pone.0034893. Epub 2012 Jul 19.

20.

Alginate scaffolds for mesenchymal stem cell cardiac therapy: influence of alginate composition.

Ceccaldi C, Fullana SG, Alfarano C, Lairez O, Calise D, Cussac D, Parini A, Sallerin B.

Cell Transplant. 2012;21(9):1969-84. doi: 10.3727/096368912X647252. Epub 2012 Jul 5.

PMID:
22776769
21.

Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats.

Alfarano C, Roubeix C, Chaaya R, Ceccaldi C, Calise D, Mias C, Cussac D, Bascands JL, Parini A.

Cell Transplant. 2012;21(9):2009-19. doi: 10.3727/096368912X640448. Epub 2012 Apr 17.

PMID:
22525800
22.

Ephrin-B1 is a novel specific component of the lateral membrane of the cardiomyocyte and is essential for the stability of cardiac tissue architecture cohesion.

Genet G, Guilbeau-Frugier C, Honton B, Dague E, Schneider MD, Coatrieux C, Calise D, Cardin C, Nieto C, Payré B, Dubroca C, Marck P, Heymes C, Dubrac A, Arvanitis D, Despas F, Altié MF, Seguelas MH, Delisle MB, Davy A, Sénard JM, Pathak A, Galés C.

Circ Res. 2012 Mar 2;110(5):688-700. doi: 10.1161/CIRCRESAHA.111.262451. Epub 2012 Feb 2.

23.

A key role for matrix metalloproteinases and neutral sphingomyelinase-2 in transplant vasculopathy triggered by anti-HLA antibody.

Galvani S, Trayssac M, Augé N, Thiers JC, Calise D, Krell HW, Sallusto F, Kamar N, Rostaing L, Thomsen M, Nègre-Salvayre A, Salvayre R.

Circulation. 2011 Dec 13;124(24):2725-34. doi: 10.1161/CIRCULATIONAHA.111.021790. Epub 2011 Nov 14.

PMID:
22082680
24.

Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1.

Pchejetski D, Foussal C, Alfarano C, Lairez O, Calise D, Guilbeau-Frugier C, Schaak S, Seguelas MH, Wanecq E, Valet P, Parini A, Kunduzova O.

Eur Heart J. 2012 Sep;33(18):2360-9. doi: 10.1093/eurheartj/ehr389. Epub 2011 Oct 25.

PMID:
22028387
25.

Evaluation of alginate microspheres for mesenchymal stem cell engraftment on solid organ.

Trouche E, Girod Fullana S, Mias C, Ceccaldi C, Tortosa F, Seguelas MH, Calise D, Parini A, Cussac D, Sallerin B.

Cell Transplant. 2010;19(12):1623-33. doi: 10.3727/096368910X514297. Epub 2010 Aug 17.

PMID:
20719065
26.

Hypomyelination associated with bovine viral diarrhea virus type 2 infection in a longhorn calf.

Porter BF, Ridpath JF, Calise DV, Payne HR, Janke JJ, Baxter DG, Edwards JF.

Vet Pathol. 2010 Jul;47(4):658-63. doi: 10.1177/0300985810370014. Epub 2010 May 6.

PMID:
20448278
27.

Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy.

Foussal C, Lairez O, Calise D, Pathak A, Guilbeau-Frugier C, Valet P, Parini A, Kunduzova O.

FEBS Lett. 2010 Jun 3;584(11):2363-70. doi: 10.1016/j.febslet.2010.04.025. Epub 2010 Apr 14.

28.

Carboplatin chemotherapy in a cat with a recurrent anal sac apocrine gland adenocarcinoma.

Wright ZM, Fryer JS, Calise DV, Oliveira FN.

J Am Anim Hosp Assoc. 2010 Jan-Feb;46(1):66-9.

PMID:
20045840
29.

Delayed treatment with plasminogen activator inhibitor-1 decoys reduces tubulointerstitial fibrosis.

Gonzalez J, Klein J, Chauhan SD, Neau E, Calise D, Nevoit C, Chaaya R, Miravete M, Delage C, Bascands JL, Schanstra JP, Buffin-Meyer B.

Exp Biol Med (Maywood). 2009 Dec;234(12):1511-8. doi: 10.3181/0903-RM-105.

PMID:
19934371
30.

HLA class I antibodies provoke graft arteriosclerosis in human arteries transplanted into SCID/beige mice.

Galvani S, Augé N, Calise D, Thiers JC, Canivet C, Kamar N, Rostaing L, Abbal M, Sallusto F, Salvayre R, Böhler T, Zou Y, Stastny P, Nègre-Salvayre A, Thomsen M.

Am J Transplant. 2009 Nov;9(11):2607-14. doi: 10.1111/j.1600-6143.2009.02804.x.

31.

Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction.

Mias C, Lairez O, Trouche E, Roncalli J, Calise D, Seguelas MH, Ordener C, Piercecchi-Marti MD, Auge N, Salvayre AN, Bourin P, Parini A, Cussac D.

Stem Cells. 2009 Nov;27(11):2734-43. doi: 10.1002/stem.169.

32.

Adipose-derived cardiomyogenic cells: in vitro expansion and functional improvement in a mouse model of myocardial infarction.

Léobon B, Roncalli J, Joffre C, Mazo M, Boisson M, Barreau C, Calise D, Arnaud E, André M, Pucéat M, Pénicaud L, Prosper F, Planat-Bénard V, Casteilla L.

Cardiovasc Res. 2009 Sep 1;83(4):757-67. doi: 10.1093/cvr/cvp167. Epub 2009 Jun 8.

PMID:
19505931
33.

Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload.

Lairez O, Calise D, Bianchi P, Ordener C, Spreux-Varoquaux O, Guilbeau-Frugier C, Escourrou G, Seif I, Roncalli J, Pizzinat N, Galinier M, Parini A, Mialet-Perez J.

J Mol Cell Cardiol. 2009 Apr;46(4):587-95. doi: 10.1016/j.yjmcc.2008.12.017. Epub 2009 Jan 7.

PMID:
19162038
34.

Interleukin-6 deficiency fails to prevent chronic rejection after aortic allografts in apolipoprotein E-deficient mice.

Yacoub-Youssef H, Blaes N, Calise D, Thiers JC, Therville N, Benoist H, Ségui B, Al Saati T, Thomsen M.

J Heart Lung Transplant. 2009 Jan;28(1):85-92. doi: 10.1016/j.healun.2008.06.012. Epub 2008 Sep 27.

PMID:
19134536
35.

Hypoxic/ischemic encephalopathy associated with placental insufficiency in a cloned foal.

Wilcox AL, Calise DV, Chapman SE, Edwards JF, Storts RW.

Vet Pathol. 2009 Jan;46(1):75-9. doi: 10.1354/vp.46-1-75.

PMID:
19112119
36.

Septicemia in a neonatal calf associated with Chromobacterium violaceum.

Ajithdoss DK, Porter BF, Calise DV, Libal MC, Edwards JF.

Vet Pathol. 2009 Jan;46(1):71-4. doi: 10.1354/vp.46-1-71.

PMID:
19112118
37.

Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy.

Klein J, Gonzalez J, Duchene J, Esposito L, Pradère JP, Neau E, Delage C, Calise D, Ahluwalia A, Carayon P, Pesquero JB, Bader M, Schanstra JP, Bascands JL.

FASEB J. 2009 Jan;23(1):134-42. doi: 10.1096/fj.08-115600. Epub 2008 Sep 22.

38.

Choosing an adipose tissue depot for sampling: factors in selection and depot specificity.

Casteilla L, Pénicaud L, Cousin B, Calise D.

Methods Mol Biol. 2008;456:23-38. doi: 10.1007/978-1-59745-245-8_2.

PMID:
18516550
39.

Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney.

Mias C, Trouche E, Seguelas MH, Calcagno F, Dignat-George F, Sabatier F, Piercecchi-Marti MD, Daniel L, Bianchi P, Calise D, Bourin P, Parini A, Cussac D.

Stem Cells. 2008 Jul;26(7):1749-57. doi: 10.1634/stemcells.2007-1000. Epub 2008 May 8.

40.

What is your diagnosis? Lingual mass in a dog.

Chapman S, Nabity M, Calise D.

Vet Clin Pathol. 2008 Mar;37(1):133-9. doi: 10.1111/j.1939-165X.2008.00018.x.

PMID:
18366557
41.

Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes.

Joffre O, Santolaria T, Calise D, Al Saati T, Hudrisier D, Romagnoli P, van Meerwijk JP.

Nat Med. 2008 Jan;14(1):88-92. Epub 2007 Dec 9.

42.

LPA1 receptor activation promotes renal interstitial fibrosis.

Pradère JP, Klein J, Grès S, Guigné C, Neau E, Valet P, Calise D, Chun J, Bascands JL, Saulnier-Blache JS, Schanstra JP.

J Am Soc Nephrol. 2007 Dec;18(12):3110-8. Epub 2007 Nov 14.

43.

Lipid and oxidative stress disorders in a rat model of chronic rejection.

Vela C, Thomsen M, Delbosc S, Calise D, Cristol JP, Mourad G.

Transplant Proc. 2007 Oct;39(8):2617-9.

PMID:
17954192
44.

Dystrophin-deficient muscular dystrophy in a Weimaraner.

Baltzer WI, Calise DV, Levine JM, Shelton GD, Edwards JF, Steiner JM.

J Am Anim Hosp Assoc. 2007 Jul-Aug;43(4):227-32.

PMID:
17615404
45.

Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis.

Pchejetski D, Kunduzova O, Dayon A, Calise D, Seguelas MH, Leducq N, Seif I, Parini A, Cuvillier O.

Circ Res. 2007 Jan 5;100(1):41-9. Epub 2006 Dec 7.

PMID:
17158340
46.

Multiple human mesenteric arterial grafts from the same donor to study human chronic vascular rejection in humanized SCID/beige mice.

Marcheix B, Yacoub-Youssef H, Calise D, Thiers JC, Therville N, Benoist H, Blaes N, Ségui B, Game X, Dambrin C, Thomsen M.

J Heart Lung Transplant. 2006 Jun;25(6):675-82. Epub 2006 May 2.

PMID:
16730573
47.

Engraftment of human T, B and NK cells in CB.17 SCID/beige mice by transfer of human spleen cells.

Yacoub-Youssef H, Marcheix B, Calise D, Thiers JC, Therville N, Benoist H, Blaes N, Ségui B, Dambrin C, Thomsen M.

Transpl Immunol. 2005 Dec;15(2):157-64. Epub 2005 Aug 8.

PMID:
16412960
48.

Human immune reconstitution with spleen cells in SCID/Beige mice.

Marcheix B, Yacoub-Youssef H, Calise D, Thiers JC, Benoist H, Blaes N, Ségui B, Thomsen M, Dambrin C.

Transplant Proc. 2005 Jul-Aug;37(6):2888-9.

PMID:
16182844
49.

Chronic vascular rejection: histologic comparison between two murine experimental models.

Yacoub-Youssef H, Marcheix B, Calise D, Thiers JC, Benoist H, Blaes N, Ségui B, Dambrin C, Thomsen M.

Transplant Proc. 2005 Jul-Aug;37(6):2886-7.

PMID:
16182843
50.

Use of human mesenteric arteries to study chronic vascular rejection in SCID/beige mice reconstituted with human spleen cells.

Yacoub-Youssef H, Marcheix B, Calise D, Thiers JC, Benoist H, Blaes N, Ségui B, Dambrin C, Thomsen M.

Transplant Proc. 2005 Jan-Feb;37(1):75-6.

PMID:
15808552

Supplemental Content

Loading ...
Support Center